Description
R-Equol is the diasteromer of S-Equol. Although S-equol is a naturally occuring isoflavone metabolite in humans, R-equol is not. However, both of these diasteromers are biologically active.
| Product Unit Size | Cost | Quantity | Stock |
|---|
R-Equol is the diasteromer of S-Equol. Although S-equol is a naturally occuring isoflavone metabolite in humans, R-equol is not. However, both of these diasteromers are biologically active.
| Cas No. | 221054-79-1 |
|---|---|
| Purity | ≥98% |
| Formula | C15H14O3 |
| Formula Wt. | 242.27 |
| Chemical Name | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol |
| IUPAC Name | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol |
| Synonym | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Lephart E. Resveratrol, 4’ acetoxy resveratrol, R-equol, racemic equol or S-equol as cosmeceuticals to improve dermal health. Int J Mol Sci. 2017 Jun 3;18(6):1193. PMID: 28587197
Setchell K, Zhao X, Jha P, et al. The pharmacokinetic behavios of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers. Am J Clin Nutr. 2009 Oct;90(4):1029-1037. PMID: 19710188
FGFR inhibitor.
Efflux pump inhibitor
EGFR inhibitor.
NSAID; COX-1/2 inhibitor.
Catechol-type flavonoid; fatty acid synthesis i...
RXR agonist.
Triterpene saponin found in Panax.
Fluoroquinolone; topoisomerase IV and bacterial...
Polyene macrolide, induces pore formation in fu...
Mycotoxin produced by Alternaria; oxidative pho...
Melanoma-associated antigen.
Impurity of everolimus
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
BRD2/3/4 inhibitor.
Polypeptide antibiotic produced from Streptomyc...
Found in Taxus, starting material for synthesis...
Amino acid alcohol.
Fibrate; PPARα agonist.
Adenosine A2A antagonist.
Fluoroquinolone; topoisomerase IV and bacterial...